Zhejiang Sachem Pharmaceutical Technology Co., Ltd. was established with a strategic focus on the pharmaceutical industry chain. Since its inception, the company has continuously strengthened its capability in resource integration and built a market-driven business system centered on enterprise needs. By identifying key links across the upstream and downstream sectors of the industry chain, we actively contribute to the overall enhancement of the pharmaceutical supply chain.

The company is committed to helping small and medium-sized manufacturers access international markets. Through the dedicated efforts of our professional international business team, we have successfully established a strong market presence for steroid hormone active pharmaceutical ingredients (APIs) and intermediates in India. Building on this solid foundation, we continue to expand our product portfolio and have formed cooperative relationships with numerous manufacturing partners across Zhejiang, Hunan, Jiangsu, and other provinces. Our products are now exported globally, reaching markets in Europe, South America, and beyond, establishing a broad and growing international sales network.

Since 2019, leveraging the support of our parent company, we have engaged in the importation, registration, and agency procurement of APIs. In collaboration with the parent company’s registration team, we have successfully introduced and registered several high-quality APIs, and established product partnerships with leading international pharmaceutical suppliers. These achievements have effectively supported joint regulatory reviews for both the parent company and domestic formulation clients.

Looking ahead, Sachem Pharma will remain ambitious, focused, and committed to continuous improvement. We aim to elevate our service standards and build a reputable corporate brand. By fully utilizing our strengths and integrating resources from both domestic and global markets, we seek to form strategic partnerships that enable synergy, mutual benefit, and shared success across the pharmaceutical industry.